Xenetic Biosciences Inc Share Price

NASDAQ: XBIO

Small Cap

$3.12

-0.15

(-4.59%)

as on September 19, 2025 at 1:29 am IST

$₹

Xenetic Biosciences Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$3.07
Day's Price Range
$3.31
$3.12
1.60%
Downside
6.09%
Upside
52 Week's Low
52 Week's High
$2.2
52-Week Price Range
$5.27
$3.12
29.49%
Downside
68.86%
Upside

Xenetic Biosciences Inc share price movements today

Previous Close: $3.27
Open: $3.31
Volume: 393.4K
Day's Low - High: $3.07 - $3.31
52 Week Low - High: $2.2 - $5.27

Xenetic Biosciences Inc Historical Returns

1 Month Return: + 11.41 %
3 Month Return: + 18.05 %
1 Year Return: -10.41 %
3 Year Return: -49.73 %
5 Year Return: -66.97 %

Xenetic Biosciences Inc Stock Fundamentals & Key Indicators

Check Xenetic Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

-2.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-5.7M

Revenue (TTM)

2.4M

Profit Margin

-126.03%

Return On Equity TTM

120810200.00%

Xenetic Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenetic Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Xenetic Biosciences Inc	SELL	$5.0M	-66.97%	NA	-126.03%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Xenetic Biosciences Inc Stock including INR - Dollar returns

The Xenetic Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y

Xenetic Biosciences Inc investment value today

Current value as on today

₹90,433

Returns

₹9,567

(-9.57%)

Returns from Xenetic Biosciences Inc Stock

₹14,521 (-14.52%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Xenetic Biosciences Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Xenetic Biosciences Inc. Average target price of $40

Xenetic Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Xenetic Biosciences Inc.

What analysts predicted

92.2%UPSIDE

Target Price

$40

Current Price

$3.12

Analyzed by

6 Analysts

Target

$40.00

Xenetic Biosciences Inc target price $40, a slight upside of 92.2% compared to current price of $3.12. According to 6 analysts rating.

Xenetic Biosciences Inc Stock's Interest Amongst Investors

Search interest for Xenetic Biosciences Inc Stock has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:-73% versus previous 30 day period

Xenetic Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	0	-1	-1	-1	-1	-1	0	-1	0	0
EBITDA	0	-1	-1	-1	-1	-1	0	-1	0	0
Interest Expense	0	-	-	0	0	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	0	-1	-1	-1	-1	-1	0	-1	0	0
Income Tax Expense	0	0	0	0	0	0	0	-	0	-
Net Income	0	-1	-1	-1	-1	-1	0	-1	0	0
Net Profit Margin	-131.71%	-161.44%	-172.71%	-174.34%	-233.96%	-175.38%	-71.09%	-162.53%	-152.23%	-116.75%

Xenetic Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	3	7	-	0	0	1	1	2	2
Gross Profit	0	2	7	0	0	0	1	1	2	2
Operating Income	-9	-47	-3	-7	-12	4	-5	-6	-4	-4
EBITDA	-9	-53	-3	-7	-9	-4	-5	-6	-4	-4
Interest Expense	0	0	0	0	0	18	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	-	-
Income Before Tax	-12	-54	-3	-7	-12	-13	-5	-6	-4	-3
Income Tax Expense	2	6	0	0	3	-2	0	0	0	-
Net Income	-12	-54	-3	-7	-15	-10	-5	-6	-4	-3
Net Profit Margin	0.00%	-1806.87%	-47.40%	0.00%	-93460.18%	-2493.11%	-477.71%	-374.17%	-162.78%	-158.39%

Xenetic Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-1	-1	-1	-1	0	-1	0	0
Operating Cash Flow	-1	0	0	-1	0	0	0	-1	0
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-	-	-	-	-
Change in Cash	-1	0	0	-1	0	0	0	-1	0

Xenetic Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-54	-3	-7	-12	-10	-5	-6	-4	-3
Operating Cash Flow	-8	1	-6	-6	-4	-4	-4	-4	-2
Investing Cash Flow	0	0	0	0	-	-	0	-	-
Financing Cash Flow	12	0	1	16	5	11	1	0	-
Change in Cash	3	1	-4	9	1	6	-5	-4	-2

Global Institutional Holdings in Xenetic Biosciences Inc

Funds	Holdings
Renaissance Technologies Corp	1.74%
Susquehanna International Group, LLP	1.65%
Citadel Advisors Llc	1.12%
Sachetta LLC	0.99%
Geode Capital Management, LLC	0.71%

See all

Insights on Xenetic Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -1.05M → -688.70K (in $), with an average increase of 24.0% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, XBIO stock has moved up by 5.5%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 78.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 161.2%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 648.82K → 589.89K (in $), with an average decrease of 4.6% per quarter

About Xenetic Biosciences Inc

xenetic biosciences (nasdaq: xbio) is a clinical-stage biopharmaceutical company focused on discovery, research and development of next-generation biologic drugs and novel oncology therapeutics. xenetic's proprietary drug development platforms include polyxen™, which enables next generation biologic drugs by improving their half-life and other pharmacological properties. xenetic's lead investigational product candidates include fda orphan designated oncology therapeutic sodium cridanimod for the treatment of progesterone receptor negative endometrial cancer, and a polysialylated form of erythropoietin for the treatment of anemia in pre-dialysis patients with chronic kidney disease. xenetic is also working together with shire plc (formerly baxalta, baxter incorporated and baxter healthcare) to develop a novel series of polysialylated blood coagulation factors, including a next generation factor viii. this collaboration relies on xenetic's polyxen technology to conjugate polysialic acid

Organisation	Xenetic Biosciences Inc
Headquarters	945 Concord Street, Framingham, MA, United States, 01701
Industry	Health Technology
CEO	Mr. James F. Parslow
E-voting on shares	Click here to vote

Key Management of Xenetic Biosciences Inc

Name	Title
Mr. James F. Parslow	CFO, COO, Interim CEO & Corporate Secretary

FAQs

What is Xenetic Biosciences Inc share price today?

Xenetic Biosciences Inc share price today is $3.12 as on September 19, 2025 at 1:29 am IST at the close of the market. Xenetic Biosciences Inc share today touched a day high of $3.31 and a low of $3.07.

What is the 52 week high and 52 week low for Xenetic Biosciences Inc share?

Xenetic Biosciences Inc share touched a 52 week high of $5.27 on June 25, 2025 and a 52 week low of $2.2 on April 7, 2025. Xenetic Biosciences Inc stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $3.12,which is 40.78% down from its 52 week high and 41.82% up from its 52 week low.

What is Xenetic Biosciences Inc's market capitalisation today?

Xenetic Biosciences Inc market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Xenetic Biosciences Inc Stock (XBIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Xenetic Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenetic Biosciences Inc Shares that will get you 0.4808 shares as per Xenetic Biosciences Inc share price of $3.12 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xenetic Biosciences Inc Stock (XBIO) from India?

Indian investors can start investing in Xenetic Biosciences Inc (XBIO) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 4:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Xenetic Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 4:40 am IST). Based on Xenetic Biosciences Inc share’s latest price of $3.12 as on September 19, 2025 at 1:29 am IST, you will get 3.2051 shares of Xenetic Biosciences Inc. Learn more about fractional shares .

What are the returns that Xenetic Biosciences Inc has given to Indian investors in the last 5 years?

Xenetic Biosciences Inc stock has given -66.97% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?